{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:02:40Z","timestamp":1760299360800},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/bmt.2016.143","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T12:51:51Z","timestamp":1464094311000},"page":"1400-1403","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["All is not lost in accelerated phase\/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand"],"prefix":"10.1038","volume":"51","author":[{"given":"P","family":"Kruger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Nivison-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Szer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"BFbmt2016143_CR1","doi-asserted-by":"crossref","unstructured":"Saussele S, Lauseker M, M\u00fcller MC, Gratwohl A, Beelen D, Bunjes DW et al2567 Allogeneic hematopoietic stem cell transplantation (HSCT) in the imatinib-era: update on the survival outcome following allogeneic HSCT after imatinib failure; results of the German CML Study IV. 56th ASH Annual Meeting and Exposition; 6\u20139 December 2014; San Francisco, CA, USA.","DOI":"10.1182\/blood.V124.21.2567.2567"},{"key":"BFbmt2016143_CR2","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408\u20132417.","journal-title":"N Engl J Med"},{"key":"BFbmt2016143_CR3","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood-2014-10-567784","volume":"125","author":"AJ Barrett","year":"2015","unstructured":"Barrett AJ, Ito S . The role of stem cell transplantation for chronic myelogenous leukaemia in the 21st century. Blood 2015; 125: 3230\u20133235.","journal-title":"Blood"},{"key":"BFbmt2016143_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1182\/blood-2006-02-001933","volume":"108","author":"E Jabbour","year":"2006","unstructured":"Jabbour E, Cortes J, Kantarjian HM, Giralt S, Jones D, Jones R et al. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure. Blood 2006; 108: 1421\u20131423.","journal-title":"Blood"},{"key":"BFbmt2016143_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.bbmt.2007.04.003","volume":"13","author":"I Nivison-Smith","year":"2007","unstructured":"Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Ma DD, Moore JJ et al. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004. Biol Blood Marrow Transplant 2007; 13: 905\u2013912.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016143_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/bmt.2011.110","volume":"47","author":"A Gratwohl","year":"2012","unstructured":"Gratwohl A . The EBMT risk score. Bone Marrow Transplant 2012; 47: 749\u2013756.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 3","key":"BFbmt2016143_CR7","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.3816\/CLM.2009.s.021","volume":"9","author":"R Champlin","year":"2009","unstructured":"Champlin R, de Lima M, Kebriaei P, Rondon G, Fisher T, Jabbour E et al. Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukaemia in the imatinib era. Clin Lymphoma Myeloma 2009; 9 (Suppl 3): S261\u2013S265.","journal-title":"Clin Lymphoma Myeloma"},{"key":"BFbmt2016143_CR8","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1182\/blood-2010-08-302679","volume":"117","author":"E Jabbour","year":"2011","unstructured":"Jabbour E, Cortes J, Santos FPS, Jones D, O\u2019Brien S, Rondon G et al. Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations. Blood 2011; 117: 3641\u20133647.","journal-title":"Blood"},{"key":"BFbmt2016143_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/bmt.2014.146","volume":"49","author":"H Jiang","year":"2014","unstructured":"Jiang H, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B et al. Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis. Bone Marrow Transplant 2014; 49: 1146\u20131154.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016143_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 2013; 122: 872\u2013874.","journal-title":"Blood"},{"key":"BFbmt2016143_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED . Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068\u20131073.","journal-title":"N Engl J Med"},{"key":"BFbmt2016143_CR12","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1182\/blood-2008-02-141689","volume":"112","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M et al. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukaemia. Blood 2008; 112: 3500\u20133507.","journal-title":"Blood"},{"key":"BFbmt2016143_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbmt.2014.09.012","volume":"21","author":"DN Egan","year":"2015","unstructured":"Egan DN, Beppu L, Radich JP . Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation. Biol Blood Marrow Transplant 2015; 21: 184\u2013189.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016143_CR14","first-page":"663","volume":"91","author":"M Weisser","year":"2006","unstructured":"Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ . A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation. Haematologica 2006; 91: 663\u2013666.","journal-title":"Haematologica"},{"key":"BFbmt2016143_CR15","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1182\/blood-2012-02-409763","volume":"119","author":"E Warlick","year":"2012","unstructured":"Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M et al. Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukaemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood 2012; 119: 4083\u20134090.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:23:11Z","timestamp":1648063391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFbmt2016143"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.143","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"assertion":[{"value":"23 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}